These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 9140298)

  • 1. The immune system following bone marrow transplantation.
    Ross DW
    Arch Pathol Lab Med; 1996 Sep; 120(9):885-6. PubMed ID: 9140298
    [No Abstract]   [Full Text] [Related]  

  • 2. Reconstitution of the B cell repertoire after bone marrow transplantation does not recapitulate human fetal development.
    Raaphorst FM
    Bone Marrow Transplant; 1999 Dec; 24(12):1267-72. PubMed ID: 10627633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone marrow transplantation: immune system suppression and reconstitution.
    Alcoser PW; Burchett S
    Am J Nurs; 1999 Jun; 99(6):26-31; quiz 32. PubMed ID: 10489556
    [No Abstract]   [Full Text] [Related]  

  • 4. Antileukemic effect of interleukin-7-transduced bone marrow stromal cells in mice following allogeneic T-cell-depleted bone marrow transplantation.
    Li AL; Li C; Feng YG; Yuan GH; Wang GM; Hao J; Gao X; Xie SS
    Transplant Proc; 2005 Jun; 37(5):2297-9. PubMed ID: 15964403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reconstruction of the haemopoietic and immune systems after marrow transplantation.
    Atkinson K
    Bone Marrow Transplant; 1990 Apr; 5(4):209-26. PubMed ID: 2186835
    [No Abstract]   [Full Text] [Related]  

  • 6. The potential role of bone marrow transplantation in augmenting donor-derived immunity to hepatitis B after rat liver transplantation.
    Li J; Dahmen U; Dirsch OR; Gu Y; Polywka S; Fiedler M; Doebel L; Roggendorf M; Broelsch CE
    Liver Transpl; 2002 Apr; 8(4):397-404. PubMed ID: 11965586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allogeneic bone marrow transplantation: relation between chimaerism and immunity.
    Vossen J
    Verh K Acad Geneeskd Belg; 1998; 60(2):111-43; discussion 143-5. PubMed ID: 9703764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ABO-incompatible organ and bone marrow transplantation: current status.
    Wu A; Bühler LH; Cooper DK
    Transpl Int; 2003 May; 16(5):291-9. PubMed ID: 12719804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [B-cell content after bone marrow transplantation--molecular basis of the limited antibody diversity].
    Vas V; Pálóczi K; Uher F
    Orv Hetil; 2001 Jan; 142(4):163-7. PubMed ID: 11232152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone marrow transplantation for sickle cell anemia: progress and prospects.
    Iannone R; Ohene-Frempong K; Fuchs EJ; Casella JF; Chen AR
    Pediatr Blood Cancer; 2005 May; 44(5):436-40. PubMed ID: 15390273
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of ex vivo activated immune cells on syngeneic and semi-allogeneic bone marrow transplantation in mice.
    Yang G; Tan J; Wei G; Deng Y; Chen H; Yang D
    Transpl Immunol; 2006 Nov; 16(3-4):166-71. PubMed ID: 17138049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Post-vaccination immunity after allogenic and autologous bone marrow transplantation].
    Skovránková J
    Cas Lek Cesk; 1999 May; 138(10):298-300. PubMed ID: 10422338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review of vascularized bone marrow transplantation: current status and future clinical applications.
    Gordon CR; Tai CY; Suzuki H; Strande LF; Ramsamooj R; Matthews MS; Black KS; Hewitt CW
    Microsurgery; 2007; 27(4):348-53. PubMed ID: 17477415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is the ABO incompatibility a risk factor in bone marrow transplantation?
    Rozman P; Kosir A; Bohinjec M
    Transpl Immunol; 2005 Aug; 14(3-4):159-69. PubMed ID: 15982558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Composite vascularized skin/bone transplantation models for bone marrow-based tolerance studies.
    Ozmen S; Ulusal BG; Ulusal AE; Izycki D; Siemionow M
    Ann Plast Surg; 2006 Mar; 56(3):295-300. PubMed ID: 16508361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune reconstitution after allogeneic stem cell transplantation: the impact of stem cell source and graft-versus-host disease.
    Abrahamsen IW; Sømme S; Heldal D; Egeland T; Kvale D; Tjønnfjord GE
    Haematologica; 2005 Jan; 90(1):86-93. PubMed ID: 15642674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular immune reconstitution and its impact on clinical outcome in children with beta thalassemia major undergoing a matched related myeloablative allogeneic bone marrow transplant.
    Rajasekar R; Mathews V; Lakshmi KM; George B; Viswabandya A; Chandy M; Srivastava A
    Biol Blood Marrow Transplant; 2009 May; 15(5):597-609. PubMed ID: 19361752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transplantation of anergic histoincompatible bone marrow cells.
    Gallardo D; Grañena A; García-López J
    N Engl J Med; 1999 Sep; 341(14):1082. PubMed ID: 10507929
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunogenicity of Ly5 (CD45)-antigens hampers long-term engraftment following minimal conditioning in a murine bone marrow transplantation model.
    van Os R; Sheridan TM; Robinson S; Drukteinis D; Ferrara JL; Mauch PM
    Stem Cells; 2001; 19(1):80-7. PubMed ID: 11209093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful renal transplantation following prior bone marrow transplantation in pediatric patients.
    Thomas SE; Hutchinson RJ; DebRoy M; Magee JC
    Pediatr Transplant; 2004 Oct; 8(5):507-12. PubMed ID: 15367289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.